Kekulé-cyclus XX: Development of New Therapies
26.03.’24
26.03.’24
Kekulé-cyclus XX: Development of New Therapies
Kekulé-cyclus XX: Our World in Transition
Avond 6: Development of New Therapies
March 26, 2024
Session Chair: Dr. Jérôme Van Biervliet (VIB - Managing Director)
Neurosciences and (rare?) diseases
Dr. Rosa Rademaekers - Center for Molecular Neurology - UAntwerp
Pharma shifts: How to organise for Personal Medicines?
Ir. Bart Van Waeyenberge – EU CAR-T Program Lead, Board of Directors Janssen Pharmaceutica NV
From basic enzymology to new medicines
Prof. dr. Chris Schofield - Dep. Chemistry - University of Oxford